Gomez, Scarlett Lin
Shariff-Marco, Salma
Cortella, Alyssa
Oh, Debora
Srivastava, Pari
Honcharov, Vlad
Duffy, Christine
Loya, Zinnia
Wadhwa, Michelle
Lau, Kathie
Olazo, Kristan
Dixit, Niharika
Sarkar, Urmimala
Funding for this research was provided by:
National Cancer Institute (R01CA241128)
Article History
Received: 9 January 2026
Accepted: 11 January 2026
First Online: 28 January 2026
Declarations
:
: Dr. Gomez was a health equity advisor for Flatiron, Inc. Dr. Dixit is a consultant for Daiichi Sankyo. Dr. Sarkar holds current research funding from the National Institutes of Health, California Healthcare Foundation, the Patient-Centered Outcomes Research Institute, and the Agency for Healthcare Research and Quality. She has received prior grant funding from the Gordon and Betty Moore Foundation, the Blue Shield of California Foundation, HopeLab, the US Food and Drug Administration, and the Commonwealth Fund. She received gift funding from The Doctors Company Foundation. She holds contract funding from InquisitHealth and RecoverX. Dr. Sarkar serves as a scientific/expert advisor for nonprofit organizations HealthTech 4 Medicaid (volunteer). She is a member of the American Medical Association’s Equity and Innovation Advisory Group (honoraria) and is on the Board of Directors of the Collaborative for Accountability and Improvement (volunteer). She is an advisor for Waymark (shares). She has served on Hopelab’s Scientific Advisory Board (2019–2023, volunteer), been a clinical advisor for Omada Health (honoraria), and an advisory board member for Doximity (honoraria, stock).